Patent · US Active

Peptide vaccines usable for hypercholesterolemia related diseases

US10933123B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignee

AFFIRIS AG · AT

Inventors

Sylvia Brunner · Wien, AT
Gergana Galabova · Wien, AT
Gabriele Winsauer · Wien, AT
Erika Bilcikova · Bratislava, SK
Claudia Juno · Wien, AT
Pola Linzmayer-Hirt · Wiener Neudorf, AT
Birgit Schuh · Wien, AT
Guenther Staffler · Wien, AT

Key dates

Filing date	May 21, 2018
Grant date	Mar 2, 2021
Priority date	—
Expiry date	Jun 7, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/6081
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a vaccine capable to induce the formation of antibodies directed to PCSK9 in vivo.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.